Global Blood Therapeutics Inc. Asset Turnover Ratio (GBT), as of second quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Global Blood Therapeutics Inc.  (NASDAQ: GBT)
 

Global Blood Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Global Blood Therapeutics's asset turnover ratio has remained unchanged compare to previous quarter at 0.3 in the second quarter (Jun 30 2022)

Within sector 75 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2022, to 1551, from total ranking in the first quarter 2022 at 2786.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GBT Asset Turnover Ratio (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Asset Change 45.45 % 37.32 % 32.26 % -12.57 % -15.52 %
Y / Y Revenue Change 50.46 % 41.28 % 35.85 % 41.1 % 50.96 %
Asset Turnover Ratio (TTM) 0.3 0.3 0.3 0.3 0.27
GBT's Total Ranking # 1551 # 2786 # 1329 # 2776 # 2582
Seq. Asset Change 0.17 % -7.84 % 59.26 % -1.07 % -5.43 %
Seq. Revenue Change 29.71 % -1.67 % 7.77 % 9.46 % 21.8 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 76
Healthcare Sector # 168
Overall Market # 1551

Asset Turnover Ratio Statistics
High Average Low
10.17 9.23 8.44
(Dec 31 2020)   (Mar 31 2022)




GBT Company Profile • Back to GBT Efficiency Comparisons • Compare GBT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2022 Assets at quarter ending Jun 30 2022
Pediatrix Medical Group Inc   0.78 $ 1,959.741  Millions$ 2,519.811  Millions
Elutia Inc   0.78 $ 46.479  Millions$ 59.963  Millions
Cartesian Therapeutics Inc   0.77 $ 127.636  Millions$ 165.202  Millions
Acadia Pharmaceuticals Inc   0.77 $ 512.401  Millions$ 663.703  Millions
Aveo Pharmaceuticals Inc   0.77 $ 79.242  Millions$ 102.689  Millions
Harvard Bioscience Inc   0.77 $ 120.704  Millions$ 157.383  Millions
Encompass Health Corporation  0.76 $ 5,267.600  Millions$ 6,903.200  Millions
Labcorp Holdings Inc   0.76 $ 15,715.200  Millions$ 20,595.850  Millions
3m Company  0.75 $ 35,085.000  Millions$ 46,709.750  Millions
Staar Surgical Co  0.75 $ 261.654  Millions$ 349.396  Millions
Journey Medical Corp  0.75 $ 78.714  Millions$ 105.185  Millions
Meridian Bioscience Inc   0.74 $ 343.547  Millions$ 461.525  Millions
Silk Road Medical Inc   0.73 $ 114.160  Millions$ 156.969  Millions
Lantheus Holdings Inc   0.73 $ 664.238  Millions$ 914.648  Millions
Inogen Inc   0.73 $ 353.269  Millions$ 486.764  Millions
Lucira Health Inc   0.72 $ 191.281  Millions$ 264.135  Millions
Cardiovascular Systems Inc   0.72 $ 236.222  Millions$ 326.335  Millions
Bruker Corporation  0.72 $ 2,475.800  Millions$ 3,428.300  Millions
U S Physical Therapy Inc  0.72 $ 528.086  Millions$ 734.958  Millions
Tenet Healthcare Corp  0.72 $ 19,133.000  Millions$ 26,690.750  Millions
Agenus Inc  0.71 $ 320.083  Millions$ 450.269  Millions
Camp4 Therapeutics Corporation  0.71 $ 280.891  Millions$ 396.964  Millions
Masimo Corp  0.71 $ 1,504.433  Millions$ 2,130.922  Millions
Nevro Corp   0.70 $ 388.020  Millions$ 553.442  Millions
Smiledirectclub Inc   0.70 $ 541.411  Millions$ 772.866  Millions
Catalyst Pharmaceuticals Inc   0.70 $ 170.465  Millions$ 243.829  Millions
Biohaven Ltd   0.69 $ 859.684  Millions$ 1,241.593  Millions
Amphastar Pharmaceuticals Inc   0.69 $ 476.920  Millions$ 690.791  Millions
Sonoma Pharmaceuticals Inc   0.69 $ 12.927  Millions$ 18.795  Millions
Fulgent Genetics Inc   0.68 $ 925.148  Millions$ 1,352.660  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.